PepsPeptide clinical trial tracker
Which peptides are actually being tested in people? For each profile, we search ClinicalTrials.gov and keep only studies that name the compound as an intervention. Checked October 8, 2026.
75 of 113 profiles have at least one registered human study; 62 have studies recruiting or active now. A registration is a plan, not a result.
Tirzepatide
Semaglutide
Oxytocin
| Study | Status | Phase | Start | People |
|---|---|---|---|---|
| Intranasal Oxytocin for Methamphetamine Withdrawal in Women NCT05760807 · Turning Point | Completed | Not applicable | 2023-03-29 | 10 |
| Effect of Intravenous Oxytocin on Post Dural Puncture Headache After Caesarean Sections NCT07853924 · Assiut University | Not yet recruiting | Phase 4 | 2026-09 | 100 |
| Effects of Intranasal Oxytocin in the Treatment of Benzodiazepine Withdrawal: A Pilot RCT NCT06757517 · St. Olavs Hospital | Completed | Phase 2 | 2022-03-01 | 66 |
| Use of Intranasal Oxytocin During Detoxification of Crack Cocaine NCT04306354 · Pontificia Universidade Católica do Rio Grande do Sul | Completed | Phase 1 / Phase 2 | 2018-09-17 | 84 |
| Efficacy of Intravenous Oxytocin to Speed Recovery After THA NCT07430228 · Wake Forest University Health Sciences | Enrolling by invitation | Phase 2 | 2026-10 | 80 |
| Oromucosal Oxytocin and Vasopressin Modulation of Emotional Face Attention NCT07838493 · University of Electronic Science and Technology of China | Recruiting | Not applicable | 2026-09-18 | 120 |
| The Effects of Oxytocin on Fairness Perception and Related Prosocial Behaviors NCT07815496 · University of Electronic Science and Technology of China | Recruiting | Not applicable | 2026-09-05 | 80 |
| Mother-Baby Study - Observational NCT06039878 · University of Michigan | Active, not recruiting | Not applicable | 2023-12-21 | 250 |
| Induction of Labor After Cesarean Using Foley Alone vs. Concurrent Foley and Oxytocin NCT07006896 · University of Pennsylvania | Active, not recruiting | Not applicable | 2025-07-10 | 100 |
| Generate and Test the Reliability of a PD Model of OXT on Pupillary Hippus as a Measure of CNS Activity NCT04427709 · Wake Forest University Health Sciences | Terminated | Phase 2 | 2020-11-30 | 4 |
| The Effect of Simulation-Based Oxytocin Induction Training on Midwifery Students' Knowledge and Anxiety Levels NCT07788495 · Melisa Gündeş | Completed | Not applicable | 2024-11-11 | 80 |
| Effect of Oxytocin Bolus Versus Slow Infusion on Haemodynamic Stability During Caesarean Section Under Spinal Anaesthesia NCT07784478 · Khyber Girls Medical College | Not yet recruiting | Not applicable | 2026-09-01 | 60 |
| Oxytocin in Postmenopausal Women NCT07742124 · University Hospital, Basel, Switzerland | Recruiting | 2026-08-20 | 30 | |
| Identifying Oxytocin Deficiency in Pediatric Patients With Pituitary Disease NCT07568509 · Massachusetts General Hospital | Recruiting | Early phase 1 | 2026-08-17 | 20 |
| Oxytocin-Augmented Group Psychotherapy for Patients With Schizophrenia - an Oxytocin-dose Comparison NCT07265180 · Charite University, Berlin, Germany | Recruiting | Not applicable | 2025-09-08 | 120 |
Leuprolide
Octreotide
Degarelix
Human insulin
Liraglutide
Mazdutide
Vasopressin
Triptorelin
Glutathione
Cagrilintide
Desmopressin
| Study | Status | Phase | Start | People |
|---|---|---|---|---|
| FESS With or Without Intranasal Desmopressin in Chronic Rhinosinusitis With Nasal Polyps NCT07855315 · Services Institute of Medical Sciences, Pakistan | Not yet recruiting | Not applicable | 2026-10-15 | 174 |
| Prophylactic Desmopressin Before Native Kidney Biopsy in Severe Renal Impairment NCT07840313 · Sindh Institute of Urology and Transplantation | Completed | Not applicable | 2017-08-01 | 250 |
| DDAVP Effect by TEG6 in Cardiac Surgery NCT07179991 · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Recruiting | 2026-08-01 | 100 | |
| Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome NCT06635629 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Recruiting | Phase 2 | 2024-12-12 | 140 |
| Bedtime Device Restriction and Desmopressin in PMNE. NCT07776977 · Al-Azhar University | Recruiting | Not applicable | 2026-08-20 | 140 |
| Randomized Controlled Clinical Study on the Prophylactic Intraoperative Use of Desmopressin in Complex Sellar Region Tumors NCT07712328 · Zhaoyun Zhang | Enrolling by invitation | Phase 4 | 2026-06-02 | 152 |
| Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial NCT06337838 · Hamilton Health Sciences Corporation | Recruiting | Phase 3 | 2025-06-09 | 100 |
| DDAVP for Pituitary Adenoma NCT04569591 · National Institute of Neurological Disorders and Stroke (NINDS) | Recruiting | Not applicable | 2026-03-09 | 22 |
| Vitamin D Versus Desmopressin Versus Combination Therapy in Children With Primary Monosymptomatic Nocturnal Enuresis and Vitamin D Deficiency NCT07292753 · Ain Shams University | Completed | Not applicable | 2024-12-15 | 90 |
| Ginkgo Biloba vs Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis NCT06771128 · Menoufia University | Completed | Not applicable | 2024-11-01 | 398 |
| Omegapres Versus Solifenacin and Mirabegron Combination Therapy in Treatment of Primary MNE NCT07199894 · Mansoura University | Recruiting | Phase 3 | 2024-12-01 | 120 |
| Bleeding Prevention With Desmopressin for Allograft Kidney Biopsies NCT06622187 · Hospital de Clinicas de Porto Alegre | Enrolling by invitation | Phase 4 | 2024-08-14 | 96 |
| Uroflowmetry and Nocturnal Enuresis NCT07028645 · Furkan Adem Canbaz | Active, not recruiting | 2022-08-20 | 100 | |
| Transfusion Reduction in High-Bleeding-Risk Cardiac Surgery With Desmopressin NCT07012837 · Imam Abdulrahman Bin Faisal University | Not yet recruiting | Phase 3 | 2025-07 | 112 |
| Systematic Use of DDAVP to Prevent Serum Sodium Overcorrection in Severe Hyponatremia NCT06020495 · Assistance Publique - Hôpitaux de Paris | Recruiting | Phase 3 | 2024-12-17 | 260 |
Teriparatide
| Study | Status | Phase | Start | People |
|---|---|---|---|---|
| Combined Anabolic Therapy NCT06558188 · Massachusetts General Hospital | Recruiting | Phase 4 | 2025-02-03 | 50 |
| PROactive HEALing in High-Risk Pelvic and Non-hip Lower Extremity Fragility Fractures (PRO HEAL Pilot) NCT06303284 · University of Calgary | Not yet recruiting | Phase 1 / Phase 2 | 2027-03-15 | 54 |
| Novel Combination Therapy for Osteoporosis in Men NCT03994172 · VA Office of Research and Development | Completed | Phase 4 | 2019-07-01 | 40 |
| Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis NCT07242612 · Khyber Medical University Peshawar | Completed | Not applicable | 2025-10-01 | 40 |
| Sequential Therapies After Osteoanabolic Treatment NCT06164795 · 424 General Military Hospital | Recruiting | 2023-11-25 | 150 | |
| Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic Acid NCT03735537 · University of Edinburgh | Completed | Phase 4 | 2016-11-01 | 350 |
| Teriparatide (Forsteo) Treatment in Postmenopausal Women: Mechanism of Action NCT01293292 · Sheffield Teaching Hospitals NHS Foundation Trust | Completed | Phase 4 | 2011-01 | 19 |
| Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover NCT05151484 · Madhumathi Rao | Active, not recruiting | Phase 4 | 2022-03-21 | 60 |
| Preoperative Teriparatide Use on Insertional Torque of Pedicle Screws for Lumbar Fusion Surgery NCT03770338 · The University of Hong Kong | Active, not recruiting | Not applicable | 2019-03-01 | 192 |
| Effects of Teriparatide (PTH) on Bone in Men and Women With Osteoporosis NCT01155232 · University Health Network, Toronto | Active, not recruiting | 2004-11 | 100 | |
| Teriparatide (PTH) and Bone Strength in Postmenopausal Women NCT01155245 · University Health Network, Toronto | Active, not recruiting | 2008-06 | 60 | |
| Precision Medicine Approach for Osteoporosis - Follow Up Study NCT06264609 · Paul F Netzel | Enrolling by invitation | Phase 4 | 2024-02-01 | 40 |
| Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous Forteo NCT05965167 · Entera Bio Ltd. | Completed | Phase 1 | 2023-05-11 | 45 |
| Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture NCT05866029 · Peking Union Medical College Hospital | Recruiting | Not applicable | 2023-05-26 | 2478 |
| Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord Injury NCT01225055 · Thomas J. Schnitzer | Completed | Phase 2 | 2010-10 | 60 |
Glucagon
Dulaglutide
Thymosin alpha-1
Vosoritide
Survodutide
Retatrutide
Cerebrolysin
Bivalirudin
Enlicitide
Calcitonin salmon
HCG
Terlipressin
Linaclotide
Abaloparatide
Cosyntropin
Lanreotide
Pasireotide
Exenatide
Ghrelin
| Study | Status | Phase | Start | People |
|---|---|---|---|---|
| Effects of Different Exercise Types on Irisin, Leptin, and Ghrelin Levels in Sedentary Women NCT07805772 · Inonu University | Not yet recruiting | Not applicable | 2026-09-05 | 20 |
| Salivary Apelin, Chemerin, Ghrelin, and Lipocalin-2 Levels in Diabetic Patients With Periodontitis NCT07703345 · Necmettin Erbakan University | Recruiting | 2026-07-01 | 88 | |
| Circulating Ghrelin as a Biomarker for Dementia NCT05381090 · Swansea University | Completed | Not applicable | 2022-08-15 | 85 |
| Ghrelin and Nutritional Status After a Standardized Meal. NCT07627802 · Medical University of Bialystok | Completed | Not applicable | 2025-04-08 | 80 |
| Unacylated Ghrelin to Improve Functioning in PAD NCT04377126 · Northwestern University | Completed | Phase 2 | 2020-07-08 | 25 |
| Effects of Antagonizing the Ghrelin Receptor on Brain Food Cue Reactivity in Obesity NCT06845033 · University Hospital, Gentofte, Copenhagen | Active, not recruiting | Not applicable | 2025-05-01 | 28 |
| Functional Proteins in Polycystic Ovary Syndrome NCT06793098 · Jagiellonian University | Recruiting | 2025-01-20 | 100 | |
| Validation of the Concept of the Autoantibodies Directed Against the Neuropeptides Involved in Food Intake Regulation on the Incidental Cases of Eating Disorders NCT03510533 · University Hospital, Rouen | Completed | Not applicable | 2018-05-24 | 211 |
| Effects of Ghrelin Administration on Motivation NCT06576440 · University Hospital Tuebingen | Completed | Not applicable | 2024-09-02 | 24 |
| Effects of Ghrelin Administration on Dopamine and Effort NCT05318924 · University Hospital Tuebingen | Completed | Phase 1 / Phase 2 | 2022-02-21 | 26 |
| Effects of Obesity and Intensity of Exercise on Ghrelin Levels NCT04581980 · University of Virginia | Completed | Not applicable | 2020-10-14 | 40 |
| Co-Feedback Action of Growth Hormone, PP and PYY on Ghrelin in Bulimia NCT03338387 · Charles University, Czech Republic | Enrolling by invitation | Phase 2 | 2003-05-06 | 24 |
| Dialectical Behavioral Therapy As A Therapeutic Tool In Patients With Binge Eating Disorder NCT05560529 · Alexandria University | Completed | Phase 4 | 2023-03-15 | 60 |
| Manipulating Ghrelin Signaling Via GOAT Inhibition in Alcohol Use Disorder NCT03896516 · National Institute on Drug Abuse (NIDA) | Completed | Phase 1 / Phase 2 | 2021-06-22 | 21 |
| Translational and Clinical Aspects of Metabolic, Anabolic and Endothelial Dysfunction in Heart Failure NCT05277415 · Lars Lund | Completed | Phase 1 / Phase 2 | 2013-02-17 | 31 |
Kisspeptin-10
| Study | Status | Phase | Start | People |
|---|---|---|---|---|
| Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism NCT04648969 · Stephanie B. Seminara, MD | Completed | Phase 2 | 2019-05-03 | 18 |
| Kisspeptin Administration Subcutaneously to Patients With IHH NCT05896293 · Stephanie B. Seminara, MD | Recruiting | Phase 2 | 2023-02-03 | 36 |
| Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea NCT07224438 · Stephanie B. Seminara, MD | Recruiting | Phase 2 | 2025-12-09 | 20 |
| Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease NCT07224490 · Stephanie B. Seminara, MD | Recruiting | Phase 1 | 2026-03-10 | 40 |
| Functional Proteins in Polycystic Ovary Syndrome NCT06793098 · Jagiellonian University | Recruiting | 2025-01-20 | 100 | |
| Recall by Genotype: Neuropeptide Stimulation NCT05901467 · Stephanie B. Seminara, MD | Terminated | Phase 1 | 2023-10-20 | 16 |
| Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Oral Glucose Tolerance Test NCT04958109 · Massachusetts General Hospital | Completed | Phase 1 | 2021-10-28 | 16 |
| Dampening the Reproductive Axis With Continuous Kisspeptin NCT05971849 · Stephanie B. Seminara, MD | Completed | Phase 1 | 2023-10-06 | 8 |
| Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders NCT05633966 · Stephanie B. Seminara, MD | Completed | Phase 1 | 2022-12-16 | 13 |
| Administration of Kisspeptin in Patients With Hyperprolactinemia NCT02956447 · Massachusetts General Hospital | Completed | Phase 2 | 2017-11-17 | 36 |
| Reproductive Hormones During Sustained Administration of Kisspeptin NCT02081924 · Imperial College London | Recruiting | Not applicable | 2014-04-02 | 76 |
| A Prospective Cohort Study on the Serum Kisspeptin Levels Throughout Pregnancy in PCOS NCT06545994 · Fudan University | Status unknown | 2024-06-28 | 180 | |
| Evaluation of Kisspeptin Stimulated Insulin Secretion With Hyperglycemic Clamp NCT05456854 · Massachusetts General Hospital | Withdrawn | Phase 1 | 2022-06-03 | 0 |
| Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Physiologic Mixed Meal Tolerance NCT04532801 · Stephanie B. Seminara, MD | Withdrawn | Phase 1 | 2019-09-01 | 0 |
| Neuropeptides in Human Reproduction NCT01952782 · Massachusetts General Hospital | Completed | Phase 1 | 2014-04-30 | 61 |
Kisspeptin-54
| Study | Status | Phase | Start | People |
|---|---|---|---|---|
| Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism NCT04648969 · Stephanie B. Seminara, MD | Completed | Phase 2 | 2019-05-03 | 18 |
| Kisspeptin Administration Subcutaneously to Patients With IHH NCT05896293 · Stephanie B. Seminara, MD | Recruiting | Phase 2 | 2023-02-03 | 36 |
| Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea NCT07224438 · Stephanie B. Seminara, MD | Recruiting | Phase 2 | 2025-12-09 | 20 |
| Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease NCT07224490 · Stephanie B. Seminara, MD | Recruiting | Phase 1 | 2026-03-10 | 40 |
| Functional Proteins in Polycystic Ovary Syndrome NCT06793098 · Jagiellonian University | Recruiting | 2025-01-20 | 100 | |
| Recall by Genotype: Neuropeptide Stimulation NCT05901467 · Stephanie B. Seminara, MD | Terminated | Phase 1 | 2023-10-20 | 16 |
| Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Oral Glucose Tolerance Test NCT04958109 · Massachusetts General Hospital | Completed | Phase 1 | 2021-10-28 | 16 |
| Dampening the Reproductive Axis With Continuous Kisspeptin NCT05971849 · Stephanie B. Seminara, MD | Completed | Phase 1 | 2023-10-06 | 8 |
| Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders NCT05633966 · Stephanie B. Seminara, MD | Completed | Phase 1 | 2022-12-16 | 13 |
| Administration of Kisspeptin in Patients With Hyperprolactinemia NCT02956447 · Massachusetts General Hospital | Completed | Phase 2 | 2017-11-17 | 36 |
| Reproductive Hormones During Sustained Administration of Kisspeptin NCT02081924 · Imperial College London | Recruiting | Not applicable | 2014-04-02 | 76 |
| A Prospective Cohort Study on the Serum Kisspeptin Levels Throughout Pregnancy in PCOS NCT06545994 · Fudan University | Status unknown | 2024-06-28 | 180 | |
| Evaluation of Kisspeptin Stimulated Insulin Secretion With Hyperglycemic Clamp NCT05456854 · Massachusetts General Hospital | Withdrawn | Phase 1 | 2022-06-03 | 0 |
| Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Physiologic Mixed Meal Tolerance NCT04532801 · Stephanie B. Seminara, MD | Withdrawn | Phase 1 | 2019-09-01 | 0 |
| Neuropeptides in Human Reproduction NCT01952782 · Massachusetts General Hospital | Completed | Phase 1 | 2014-04-30 | 61 |
Setmelanotide
Lixisenatide
Teduglutide
NAD+
| Study | Status | Phase | Start | People |
|---|---|---|---|---|
| PEDIatric Cardiac Dysfunction Treated With Injectable Nicotinamide Adenine Dinucleotide NCT07839130 · Beijing Children's Hospital | Not yet recruiting | Phase 2 | 2026-10-01 | 180 |
| A Clinical Trial to Assess the Absorption, Safety, and Efficacy of an Oral Nicotinamide Adenine Dinucleotide (NAD+) Supplement in Healthy Adults NCT07692633 · Reus Research | Not yet recruiting | Not applicable | 2026-08 | 80 |
| Nicotinamide Adenine Dinucleotide Responses to a Nutritional Supplement NCT07428889 · Shaklee Corporation | Completed | Not applicable | 2026-02-17 | 29 |
| Nicotinamide Adenine Dinucleotide (NAD+) Metabolism in Human Brown Adipose Tissue NCT06627868 · University of Turku | Recruiting | Not applicable | 2024-11-20 | 68 |
| NADream: Effects of Nicotinamide Adenine Dinucleotide Supplementation on Sleep Quality in Healthy Individuals NCT06971224 · Haukeland University Hospital | Recruiting | Phase 2 | 2025-10-13 | 16 |
Pramlintide
| Study | Status | Phase | Start | People |
|---|---|---|---|---|
| Postprandial Regulation of Bone Perfusion in Healthy Individuals NCT07679516 · University of Copenhagen | Not yet recruiting | Not applicable | 2026-07-19 | 15 |
| Two Way Crossover Closed Loop Study Insulin vs Insulin and Pramlintide NCT06422325 · Oregon Health and Science University | Completed | Not applicable | 2024-07-12 | 33 |
| Multi-Center Development of a Novel Diagnostic Test for Alzheimer's Disease NCT03560960 · Boston University | Active, not recruiting | Early phase 1 | 2020-02-04 | 57 |
| Tailoring Obesity Treatment Trial NCT06619015 · Esbjerg Hospital - University Hospital of Southern Denmark | Withdrawn | Phase 2 / Phase 3 | 2025-04-01 | 0 |
| Pancreatic Polypeptide as a Modulator of Amylin- Induced Satiety in Healthy Humans NCT07506369 · University Hospital, Gentofte, Copenhagen | Recruiting | Not applicable | 2026-04 | 18 |
| A Fully Automated Lyumjev and Pramlintide Delivery System for Adults With Type 1 Diabetes NCT06046417 · McGill University Health Centre/Research Institute of the McGill University Health Centre | Status unknown | Phase 2 / Phase 3 | 2023-11-30 | 30 |
| Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D NCT04074317 · Xeris Pharmaceuticals | Completed | Phase 2 | 2019-08-22 | 18 |
| The Role of Amylin in Bone Metabolism NCT06186063 · Filip Krag Knop | Status unknown | Not applicable | 2024-02-12 | 20 |
| A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 Diabetes NCT05199714 · McGill University Health Centre/Research Institute of the McGill University Health Centre | Completed | Not applicable | 2022-02-21 | 12 |
| Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass Surgery NCT01841359 · Joslin Diabetes Center | Completed | Phase 4 | 2010-02-02 | 22 |
| Biological Outcomes of Pramlintide in Resectable Cutaneous Squamous Cell Carcinoma: A Pilot Study NCT04252612 · H. Lee Moffitt Cancer Center and Research Institute | Withdrawn | Early phase 1 | 2020-01-30 | 0 |
| Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 Diabetes NCT04243629 · McGill University | Status unknown | Not applicable | 2021-11-12 | 26 |
| A Study of the Functional Magnetic Resonance Imaging Response to Leptin and Pramlintide NCT00691158 · Oregon Health and Science University | Status unknown | Not applicable | 2006-01 | 10 |
| Alleviating Carbohydrate Counting for Patients With Type 1 Diabetes Using a Novel Insulin-plus-pramlintide Artificial Pancreas NCT04163874 · McGill University | Completed | Not applicable | 2020-02-14 | 36 |
| Glucagon Counterregulation in Type 1 Diabetes NCT03547427 · University of Virginia | Terminated | Not applicable | 2018-05-20 | 13 |
Elamipretide
Thymosin beta-4
Tesamorelin
Ziconotide
Pemvidutide
PACAP-38
MOTS-c
| Study | Status | Phase | Start | People |
|---|---|---|---|---|
| Comparison of the Effects of General Anesthesia and Combined Spinal-Epidural Anesthesia on Ferroptosis, Humanin and MOTS-c Levels in Renal Transplantation NCT07678073 · University of Gaziantep | Recruiting | Not applicable | 2026-03-01 | 68 |
| MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity NCT07505745 · Hudson Biotech | Recruiting | Phase 2 | 2026-02-02 | 120 |
| Platelet Reactivity, B-amyloid, MOTS-c and Mortality of Type II Diabetics With CAD NCT04027712 · University of Athens | Status unknown | 2014-01-01 | 120 |
BPC-157
| Study | Status | Phase | Start | People |
|---|---|---|---|---|
| Impact of BPC-157 on Recovery Following Rotator Cuff Repair Surgery NCT07803250 · University of Arkansas | Not yet recruiting | Phase 1 | 2027-01-01 | 30 |
| BPC 157 for Acute Hamstring Muscle Strain Repair NCT07437547 · Hudson Biotech | Recruiting | Phase 2 | 2026-02-02 | 120 |
GHK-Cu
| Study | Status | Phase | Start | People |
|---|---|---|---|---|
| Two-Part Study of the Effects of the X39 Patch on Circulating GHK and GHK-Cu Levels in Healthy Adults NCT07706361 · LifeWave, Inc. | Not yet recruiting | Not applicable | 2027-01 | 100 |
| Topical GHK-Cu Gel for Acute Skin Wound Healing NCT07437586 · Hudson Biotech | Recruiting | Phase 2 | 2026-02-02 | 60 |
L-Carnosine
Afamelanotide
LL-37
VIP
Plecanatide
Bremelanotide
Neuropeptide Y
| Study | Status | Phase | Start | People |
|---|---|---|---|---|
| Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN) NCT04838678 · University of Texas Southwestern Medical Center | Recruiting | Early phase 1 | 2021-07-18 | 100 |
| Neuropeptide Y Regulates Neurogenic Pulp Inflammation NCT06606236 · Institucion Universitaria Colegios de Colombia | Completed | Not applicable | 2024-02-05 | 40 |
| Moxonidine Effects on Neuropeptide Y NCT05147753 · Aristotle University Of Thessaloniki | Completed | Phase 4 | 2010-01-11 | 90 |
| Sex Differences in Neuropeptide Y Serum, But Not in Fat Intake and Body Mass Index NCT04650308 · Universitas Sumatera Utara | Completed | Not applicable | 2020-04-02 | 62 |
| Intranasal Neuropeptide Y in Clinical Trial in Level Two Trauma Patients for PTSD and Acute Stress Disorder NCT04071600 · New York Medical College | Status unknown | Phase 1 / Phase 2 | 2019-11-01 | 117 |
| Neuropeptide Y and Sympathovagal Balance NCT03933787 · Eric Grouzmann | Completed | Early phase 1 | 2018-06-05 | 7 |
| Effect of DPP4 Inhibition on Vasoconstriction NCT02639637 · Vanderbilt University | Completed | Phase 4 | 2015-12 | 18 |
| Intranasal Administration of Neuropeptide Y in Healthy Male Volunteers NCT00748956 · Dennis Charney | Completed | Phase 2 | 2010-01 | 10 |
| A Dose Escalation Study of Intranasal Neuropeptide Y in Post Traumatic Stress Disorder (PTSD) NCT01533519 · James Murrough | Completed | Phase 1 | 2012-12 | 26 |
| Neuropeptide Y (NPY) Regulation of Nociceptors NCT00596193 · The University of Texas Health Science Center at San Antonio | Completed | 2001-05 | 11 |
Thymopentin
Nisotirostide
| Study | Status | Phase | Start | People |
|---|---|---|---|---|
| A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide NCT06897475 · Eli Lilly and Company | Recruiting | Phase 2 | 2025-03-28 | 200 |
| A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes NCT05377333 · Eli Lilly and Company | Completed | Phase 1 | 2022-06-02 | 94 |
| A Study of LY3457263 in Obese Participants NCT05582096 · Eli Lilly and Company | Completed | Phase 1 | 2022-11-11 | 38 |
| A Study of LY3457263 in Healthy Participants and Participants With Type 2 Diabetes NCT04641312 · Eli Lilly and Company | Completed | Phase 1 | 2020-11-25 | 67 |
Humanin
| Study | Status | Phase | Start | People |
|---|---|---|---|---|
| Comparison of the Effects of General Anesthesia and Combined Spinal-Epidural Anesthesia on Ferroptosis, Humanin and MOTS-c Levels in Renal Transplantation NCT07678073 · University of Gaziantep | Recruiting | Not applicable | 2026-03-01 | 68 |
| Clinical Value of Plasma Humanin in Acute Kidney Injury NCT06105229 · Guangdong Provincial People's Hospital | Status unknown | 2022-08-01 | 60 | |
| Humanin Isoforms in Cardiac Muscle and Blood Plasma and Major Complications After Cardiac Operation NCT03431844 · University of Tartu | Completed | 2018-01-01 | 106 |
Melanotan II
| Study | Status | Phase | Start | People |
|---|---|---|---|---|
| Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo NCT07437560 · Hudson Biotech | Recruiting | Phase 2 | 2026-02-02 | 60 |
| Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers (MT-2) NCT04073433 · Resilient Pharmaceuticals | Withdrawn | Phase 1 | 2024-12 | 0 |
TB-500
| Study | Status | Phase | Start | People |
|---|---|---|---|---|
| TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD NCT07487363 · Hudson Biotech | Recruiting | Phase 1 / Phase 2 | 2026-02-05 | 80 |
Enfuvirtide
Peptide YY
Larazotide
TRH (thyrotropin-releasing hormone)
Orexin-A
| Study | Status | Phase | Start | People |
|---|---|---|---|---|
| Spectrometry (MRM) Versus I 125 Radioimmunoassay (RIA) for Quantification of Orexin-A of Patients With Hypersomnolence NCT05615584 · University Hospital, Montpellier | Completed | Not applicable | 2023-02-15 | 117 |
| Digital Addiction, Sleep Quality and Orexin-A Level NCT06738524 · Amasya University | Completed | Not applicable | 2024-02-01 | 42 |
| Orexin-A Levels in Insomnia Patients NCT05664295 · Muğla Sıtkı Koçman University | Completed | 2022-12-30 | 60 | |
| The Value of Combined Detection of Orexin-A, HLA Gene, PSG and MSLT in the Evaluation of Patients With Narcolepsy NCT04940806 · Qianfoshan Hospital | Status unknown | 2021-05-01 | 120 | |
| Plasma Orexin A and mRNA Expression Levels of Pre-pro-orexin Gene in Attention-Deficit Hyperactivity Disorder NCT02074176 · National Taiwan University Hospital | Status unknown | 2011-01 | 50 | |
| Difference of Plasma Orexin A Levels Between Elderly and Young Patients at Emergence NCT01478906 · Xijing Hospital | Status unknown | 2011-07 | 40 |
Efpeglenatide
| Study | Status | Phase | Start | People |
|---|---|---|---|---|
| Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise NCT03353350 · Hanmi Pharmaceutical Company Limited | Completed | Phase 3 | 2017-12-05 | 406 |
| Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Alone or in Combination With Sulfonylurea NCT03770728 · Sanofi | Terminated | Phase 3 | 2019-08-01 | 312 |
| Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s) NCT03713684 · Sanofi | Terminated | Phase 3 | 2018-11-09 | 370 |
| Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin NCT03684642 · Sanofi | Terminated | Phase 3 | 2018-09-26 | 908 |
| Effect of Efpeglenatide on Cardiovascular Outcomes NCT03496298 · Sanofi | Terminated | Phase 3 | 2018-04-27 | 4076 |
Argireline
| Study | Status | Phase | Start | People |
|---|---|---|---|---|
| Topical Acetyl Hexapeptide-8 and the Cosmetic Appearance of Oily Skin NCT02597777 · University of California, Davis | Completed | Not applicable | 2016-01 | 14 |
| Acetyl Hexapeptide-8 for Blepharospasm NCT01750346 · National Institute of Neurological Disorders and Stroke (NINDS) | Terminated | Phase 2 | 2012-11 | 8 |
| A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm NCT00942851 · National Institute of Neurological Disorders and Stroke (NINDS) | Completed | Phase 1 / Phase 2 | 2009-07 | 24 |
| Argireline in Treatment of Periorbital Wrinkles NCT01381484 · Mahidol University | Completed | Phase 3 | 2009-03 | 70 |
Nesfatin-1
| Study | Status | Phase | Start | People |
|---|---|---|---|---|
| Serum Nesfatin-1 and Human Cartilage Glycoprotein-39 Levels in Knee Osteoarthritis NCT06254976 · Kayseri City Hospital | Completed | Not applicable | 2022-06-01 | 30 |
| Nesfatin-1 Level in Patients With Type 2 Diabetes, Insulin Resistance and Obesity NCT04298515 · Istanbul Medeniyet University | Status unknown | Not applicable | 2020-03-02 | 180 |
| Role of Nesfatin-1 and Nicotinamide in Infertile Women With Polycystic Ovary Syndrome NCT03870035 · Assiut University | Status unknown | 2019-05-01 | 56 | |
| Cord Blood Nesfatin-1 and Irisin in the Intrauterine Growth Restricted Fetuses NCT03808571 · Yuzuncu Yil University | Completed | 2018-01-01 | 66 |
MK-677
| Study | Status | Phase | Start | People |
|---|---|---|---|---|
| The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease NCT05364684 · Massachusetts General Hospital | Completed | Phase 2 | 2022-08-10 | 12 |
| Efficacy and Safety of an Oral Growth Hormone Drug in the Treatment of Fibromyalgia NCT00116129 · Bennett, Robert, M.D. | Completed | Phase 2 | 2005-07 | 64 |
| Effects of an Oral GH Secretagogue (MK-677) on Body Composition and Functional Ability of Older Adults NCT00474279 · University of Virginia | Completed | Phase 1 / Phase 2 | 1998-07 | 72 |
ARA-290
| Study | Status | Phase | Start | People |
|---|---|---|---|---|
| Study of Efficacy of ARA 290 on Corneal Nerve Fiber Density and Neuropathic Symptoms of Subjects With Sarcoidosis NCT02039687 · Araim Pharmaceuticals, Inc. | Completed | Phase 2 | 2014-01 | 64 |
| ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes) NCT01933529 · Claes-Göran Östenson | Status unknown | Phase 2 | 2013-10 | 24 |
Ipamorelin
| Study | Status | Phase | Start | People |
|---|---|---|---|---|
| Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus NCT00672074 · Helsinn Therapeutics (U.S.), Inc | Completed | Phase 2 | 2008-04 | 117 |
| Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function NCT01280344 · Helsinn Therapeutics (U.S.), Inc | Completed | Phase 2 | 2011-04 | 320 |
CJC-1295
| Study | Status | Phase | Start | People |
|---|---|---|---|---|
| A Study to Evaluate CJC 1295 in HIV Patients With Visceral Obesity NCT00267527 · ConjuChem | Terminated | Phase 2 | 2005-12 | 120 |
Peptide bioregulators (Khavinson peptides)
| Study | Status | Phase | Start | People |
|---|---|---|---|---|
| Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning NCT01424774 · Bracco Diagnostics, Inc | Completed | 2011-09 | 155 |
No registered human trials found
5-Amino-1MQ, Adipotide, AHK-Cu, AOD-9604, B7-33, Cortistatin, Dihexa, DSIP, Epitalon, Follistatin 344, FOXO4-DRI, GHK, GHRP-2, GHRP-6, Gonadorelin, Hexarelin, HGH Fragment 176-191, IGF-1 DES, IGF-1 LR3, KPV, Matrixyl, MGF, Modified GRF 1-29, N-Acetyl Selank, NA-Semax Amidate, P21, PE-22-28, PEG-MGF, Pinealon, PNC-27, PTD-DBM, Selank, Semax, Sermorelin, SLU-PP-332, SNAP-8, Thymalin, Thymulin
Searches use each profile's name and main aliases. A missing registration is not proof that no human study exists, but most published human research in the U.S. and Europe is registered.